7BGX
 
 | | Mutant F105L of recombinant beta-lactoglobulin | | 分子名称: | Beta-lactoglobulin, GLYCEROL, SULFATE ION | | 著者 | Loch, J.I, Wrobel, P, Lewinski, K. | | 登録日 | 2021-01-08 | | 公開日 | 2021-01-27 | | 最終更新日 | 2024-01-31 | | 実験手法 | X-RAY DIFFRACTION (2 Å) | | 主引用文献 | Interactions of new lactoglobulin variants with tetracaine: crystallographic studies of ligand binding to lactoglobulin mutants possessing single substitution in the binding pocket.
Acta Biochim.Pol., 68, 2021
|
|
6XVE
 | |
7BF8
 | |
7BF9
 | |
7BH0
 | |
7BF7
 | |
7BGA
 | |
7BGZ
 | | Mutant L39K of recombinant beta-lactoglobulin in complex with endogenous ligand | | 分子名称: | 1,2-ETHANEDIOL, Beta-lactoglobulin, DECANOIC ACID | | 著者 | Loch, J.I, Siuda, M.K, Lewinski, K. | | 登録日 | 2021-01-09 | | 公開日 | 2021-01-27 | | 最終更新日 | 2024-01-31 | | 実験手法 | X-RAY DIFFRACTION (2.401 Å) | | 主引用文献 | Interactions of new lactoglobulin variants with tetracaine: crystallographic studies of ligand binding to lactoglobulin mutants possessing single substitution in the binding pocket.
Acta Biochim.Pol., 68, 2021
|
|
7Q19
 | | Beta-lactoglobulin mutant FAW (I56F/L39A/M107W) in complex with desipramine (FAW-DSM#3) | | 分子名称: | 1,2-ETHANEDIOL, 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE, Beta-lactoglobulin, ... | | 著者 | Loch, J.I, Barciszewski, J, Pokrywka, K, Lewinski, K. | | 登録日 | 2021-10-18 | | 公開日 | 2022-05-11 | | 最終更新日 | 2024-01-31 | | 実験手法 | X-RAY DIFFRACTION (1.55 Å) | | 主引用文献 | New ligand-binding sites identified in the crystal structures of [beta]-lactoglobulin complexes with desipramine
Iucrj, 9, 2022
|
|
7Q2N
 | | Beta-lactoglobulin mutant FAF (I56F/L39A/M107F) in complex with desipramine (FAF-DSM) | | 分子名称: | 1,2-ETHANEDIOL, 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE, Beta-lactoglobulin, ... | | 著者 | Loch, J.I, Barciszewski, J, Lewinski, K. | | 登録日 | 2021-10-25 | | 公開日 | 2022-05-11 | | 最終更新日 | 2024-01-31 | | 実験手法 | X-RAY DIFFRACTION (1.7 Å) | | 主引用文献 | New ligand-binding sites identified in the crystal structures of [beta]-lactoglobulin complexes with desipramine
Iucrj, 9, 2022
|
|
7Q2P
 | | Beta-lactoglobulin mutant FAW (I56F/L39A/M107W) in complex with desipramine (FAW-DSM#2) | | 分子名称: | 1,2-ETHANEDIOL, 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE, Beta-lactoglobulin, ... | | 著者 | Loch, J.I, Barciszewski, J, Pokrywka, K, Lewinski, K. | | 登録日 | 2021-10-25 | | 公開日 | 2022-05-11 | | 最終更新日 | 2024-01-31 | | 実験手法 | X-RAY DIFFRACTION (1.69 Å) | | 主引用文献 | New ligand-binding sites identified in the crystal structures of [beta]-lactoglobulin complexes with desipramine
Iucrj, 9, 2022
|
|
7Q18
 | | Beta-lactoglobulin mutant FAF (I56F/L39A/M107F), unliganded form | | 分子名称: | Beta-lactoglobulin, SULFATE ION | | 著者 | Loch, J.I, Cymborowski, M.T, Minor, W, Lewinski, K. | | 登録日 | 2021-10-18 | | 公開日 | 2022-05-11 | | 最終更新日 | 2024-01-31 | | 実験手法 | X-RAY DIFFRACTION (1.804 Å) | | 主引用文献 | New ligand-binding sites identified in the crystal structures of [beta]-lactoglobulin complexes with desipramine
Iucrj, 9, 2022
|
|
7Q17
 | | Beta-lactoglobulin mutant FAW (I56F/L39A/M107W), unliganded form | | 分子名称: | 1,2-ETHANEDIOL, Beta-lactoglobulin | | 著者 | Loch, J.I, Barciszewski, J, Lewinski, K. | | 登録日 | 2021-10-18 | | 公開日 | 2022-05-11 | | 最終更新日 | 2024-01-31 | | 実験手法 | X-RAY DIFFRACTION (1.8 Å) | | 主引用文献 | New ligand-binding sites identified in the crystal structures of [beta]-lactoglobulin complexes with desipramine
Iucrj, 9, 2022
|
|
7Q2O
 | | Beta-lactoglobulin mutant FAW (I56F/L39A/M107W) in complex with desipramine (FAW-DSM#1) | | 分子名称: | 1,2-ETHANEDIOL, 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE, Beta-lactoglobulin, ... | | 著者 | Loch, J.I, Barciszewski, J, Lewinski, K. | | 登録日 | 2021-10-25 | | 公開日 | 2022-05-11 | | 最終更新日 | 2024-01-31 | | 実験手法 | X-RAY DIFFRACTION (1.8 Å) | | 主引用文献 | New ligand-binding sites identified in the crystal structures of [beta]-lactoglobulin complexes with desipramine
Iucrj, 9, 2022
|
|
6QI6
 | | Trigonal form of WT recombinant bovine beta-lactoglobulin | | 分子名称: | 1,2-ETHANEDIOL, Beta-lactoglobulin, ETHANOL | | 著者 | Loch, J.I, Krawczyk, A, Lewinski, K. | | 登録日 | 2019-01-17 | | 公開日 | 2019-01-30 | | 最終更新日 | 2024-01-24 | | 実験手法 | X-RAY DIFFRACTION (2 Å) | | 主引用文献 | Structure-based design approach to rational site-directed mutagenesis of beta-lactoglobulin.
J.Struct.Biol., 210, 2020
|
|
6QI7
 | | Engineered beta-lactoglobulin: variant L39Y in complex with endogenous ligand | | 分子名称: | 1,2-ETHANEDIOL, Beta-lactoglobulin, PALMITIC ACID | | 著者 | Loch, J.I, Siuda, M.K, Lewinski, K. | | 登録日 | 2019-01-17 | | 公開日 | 2019-01-30 | | 最終更新日 | 2024-01-24 | | 実験手法 | X-RAY DIFFRACTION (2.5 Å) | | 主引用文献 | Structure-based design approach to rational site-directed mutagenesis of beta-lactoglobulin.
J.Struct.Biol., 210, 2020
|
|
6QPD
 | |
6QPE
 | |
6RWP
 | |
6RWQ
 | | Engineered beta-lactoglobulin: variant F105L in complex with myristic acid | | 分子名称: | 1,2-ETHANEDIOL, Beta-lactoglobulin, MYRISTIC ACID | | 著者 | Loch, J.I, Gotkowski, M, Lewinski, K. | | 登録日 | 2019-06-05 | | 公開日 | 2019-06-19 | | 最終更新日 | 2024-01-24 | | 実験手法 | X-RAY DIFFRACTION (2.05 Å) | | 主引用文献 | Structure-based design approach to rational site-directed mutagenesis of beta-lactoglobulin.
J.Struct.Biol., 210, 2020
|
|
6RWR
 | |
6RYT
 | |
